<p><i>IGHV</i> mutational status homology ≥ 98%: M, mutated; UM, unmutated. ZAP70 is considered negative when the ratio (<i>R</i>) of mean fluorescence of T lymphocytes/mean fluorescence of CLL B lymphocytes ≥ 12. ZAP70 is considered positive if <i>R</i> ≤ 10, and “grey zone” if 10 < <i>R</i> < 12. CD38 is considered positive when the percentage of positive leukemic cells is ≥30%. FISH: score of interphasic cells with an abnormality. Complex karyotype is ≥3 chromosomal abnormalities. bi, biallelic; Del, deletion; mono, monoallelic; nd, not done.</p><p>Features of CLL patients with clinical Binet Stage A.</p
The clinical heterogeneity that characterizes chronic lymphocytic leukemia (CLL), with survival time...
Chromosomal abnormalities in chronic lymphocytic leukemia (CLL) are detected in up to 80% of patient...
Chronic lymphocytic leukemia (CLL) patients with differential somatic hypermutation status of the im...
<p><i>IGHV</i> mutational status homology ≥ 98%: M, mutated; UM, unmutated. ZAP70 is considered nega...
Background. The clinical heterogeneity of chronic lymphocytic leukemia (CLL) requires parameters to ...
Background. The clinical heterogeneity of chronic lymphocytic leukemia (CLL) requires parameters to ...
Background. Biologic risk factors such as immunoglobulin variable heavy chain (IgVH) gene mutation s...
The diagnosis of chronic lymphocytic leukaemia (CLL) is based on clinical and laboratory features. M...
a<p>Clinical stage according to references <a href="http://www.plosone.org/article/info:doi/10.1371/...
The clinical course of chronic lymphocytic leukemia (CLL) is extremely heterogeneous and while some ...
Chronic Lymphocytic Leukemia (CLL) is a type of cancer that affects the B cells of the immune system...
Background. Chronic lymphocytic leukemia (CLL) is a disease with a high variability in clinical pres...
Background. Chronic lymphocytic leukemia (CLL) is a clinically heterogeneous disease. Adverse progno...
This thesis is focused on mutation status and other chromosomal changes in chronic lymphocytic leuke...
In chronic lymphocytic leukaemia (CLL), caution is warranted regarding the clinical implications of ...
The clinical heterogeneity that characterizes chronic lymphocytic leukemia (CLL), with survival time...
Chromosomal abnormalities in chronic lymphocytic leukemia (CLL) are detected in up to 80% of patient...
Chronic lymphocytic leukemia (CLL) patients with differential somatic hypermutation status of the im...
<p><i>IGHV</i> mutational status homology ≥ 98%: M, mutated; UM, unmutated. ZAP70 is considered nega...
Background. The clinical heterogeneity of chronic lymphocytic leukemia (CLL) requires parameters to ...
Background. The clinical heterogeneity of chronic lymphocytic leukemia (CLL) requires parameters to ...
Background. Biologic risk factors such as immunoglobulin variable heavy chain (IgVH) gene mutation s...
The diagnosis of chronic lymphocytic leukaemia (CLL) is based on clinical and laboratory features. M...
a<p>Clinical stage according to references <a href="http://www.plosone.org/article/info:doi/10.1371/...
The clinical course of chronic lymphocytic leukemia (CLL) is extremely heterogeneous and while some ...
Chronic Lymphocytic Leukemia (CLL) is a type of cancer that affects the B cells of the immune system...
Background. Chronic lymphocytic leukemia (CLL) is a disease with a high variability in clinical pres...
Background. Chronic lymphocytic leukemia (CLL) is a clinically heterogeneous disease. Adverse progno...
This thesis is focused on mutation status and other chromosomal changes in chronic lymphocytic leuke...
In chronic lymphocytic leukaemia (CLL), caution is warranted regarding the clinical implications of ...
The clinical heterogeneity that characterizes chronic lymphocytic leukemia (CLL), with survival time...
Chromosomal abnormalities in chronic lymphocytic leukemia (CLL) are detected in up to 80% of patient...
Chronic lymphocytic leukemia (CLL) patients with differential somatic hypermutation status of the im...